2025-01-09 《人物與企業特寫》以科技為核心的TechBio新時代—Chris Gibson博士與Recursion Pharmaceuticals 《人物與企業特寫》以科技為核心的TechBio新時代—Chris Gibson博士與Recursion Pharmaceuticals 閱讀全文 »
2024-12-10 美國FDA藥物法規監管的紅利—Fast Track, Breakthrough Therapy, Accelerated Approval, Priority Review, and Orphan Drug (下) 美國FDA藥物法規監管的紅利—Fast Track, Breakthrough Therapy, Accelerated Approval, Priority Review, and Orphan Drug (下) 閱讀全文 »
2024-12-10 美國FDA藥物法規監管的紅利—Fast Track, Breakthrough Therapy, Accelerated Approval, Priority Review, and Orphan Drug (中) 美國FDA藥物法規監管的紅利—Fast Track, Breakthrough Therapy, Accelerated Approval, Priority Review, and Orphan Drug (中) 閱讀全文 »
2024-12-03 美國FDA藥物法規監管的紅利—Fast Track, Breakthrough Therapy, Accelerated Approval, Priority Review, and Orphan Drug (上) 美國FDA藥物法規監管的紅利—Fast Track, Breakthrough Therapy, Accelerated Approval, Priority Review, and Orphan Drug (上) 閱讀全文 »
